Prevalence of 677T polymorphism in the MTHFR gene in a sample population of Nuevo Leon, Mexico;Prevalencia del polimorfismo 677T del gen MTHFR en una muestra de la población de Nuevo León, México

Salud Publica de Mexico

Volumn 50, Issue 1, 2008, Pages 5-7

  Aguirre Rodríguez, Ana Alejandra ^a   Martínez de Villarreal, Laura Elia ^a   Velazco Campos, María Del Roble ^a   Sampallo Hernández, Ernestina ^a   Esmer Sánchez, María Del Carmen ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; HYPERHOMOCYSTEINEMIA; LETTER; MALE; MEXICO; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MEXICO; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 42349111433     PISSN: 00363634     EISSN: 16067916     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. Martínez LE, Delgado I, Valdez R, Ortiz R, Rojas A, Limón C et al. Folate levels and N5, N10-methylenetetrahidrofolate reductase genotype (MTHFR) in mothers of offspring with neural tube defects: a case-control study. Arch Med Res 2001;32:277-282.
2. Goyette P, Summer JS, Milos R, Duncan AMV, Rosenblatt DS, Matthews RG, et al. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet 1994;7:195-200.
3. Martin YN, Salavaggione OE, Eckloff BW, Wieben ED, Schaid DJ, Weinshilboum RM. Human methylenetetrahydrofolate reductase pharmacogenomics: gene resequencing and functional genomics. Pharmacogenet Genomics 2006;16:265-277.
4. Dávalos IP, Olivares N, Castillo MT, Cantú JM, Ibarra B, Sandoval L, et al. The C677T polymorphism of the methylenetetrahydrofolate reductase gene in mexican mestizo and native populations. Ann Gen 2000;43:89-92.
5. Mutchinick OM, López MA, Luna L, Waxman J, Babinsky VE and the RYVEMCE Collaborative Group. High prevalence of the thermolabile methylenetetrahydrofolate reductase variant in Mexico: a country with a very high prevalence of neural tube defects. Mol Gen Metab 1999;68:461-467.
6. González L, García G, Castillo I, Canto J, Orozco L. Frequency of the thermolabile variant C677T in the MTHFR gene and lack of association with neural tube defects in the state of Yucatán, Mexico. Clin Genet 2002;62:394-398.
7. Chávez DV. Asociación de ácido fólico, homocisteína y polimorfismo genético de la MTHFR con DRN y labio hendido con y sin paladar hendido en Chihuahua (tesis). Chihuahua: Universidad Autónoma de Chihuahua, 2004.
8. Guéant RM, Guéant JL, Debard R, Thirion S, Hong LX, Bronowicki JP, et al. Prevalence of methylenetetrahydrofolate reductase 677T and 1298C alleles and folate status: a comparative study in Mexican, West African, and European populations. Am J Clin Nutr 2006;83:701-707.
9. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996;93:7-9.
10. Martin YN, Salavaggione OE, Eckloff BW, Wieben ED, Schaid DJ, Weinshilboum RM. Homocysteine lowering trialists collaboration. Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr 2005;82:806-812.